-
Je něco špatně v tomto záznamu ?
The β-N-Acetylhexosaminidase in the Synthesis of Bioactive Glycans: Protein and Reaction Engineering
P. Bojarová, N. Kulik, M. Hovorková, K. Slámová, H. Pelantová, V. Křen,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
LTC18038
Ministerstvo Školství, Mládeže a Tělovýchovy
NLK
Directory of Open Access Journals
od 1997
Free Medical Journals
od 1997
PubMed Central
od 2001
Europe PubMed Central
od 2001
ProQuest Central
od 1997-01-01
Open Access Digital Library
od 1997-01-01
Medline Complete (EBSCOhost)
od 2009-03-01
Health & Medicine (ProQuest)
od 1997-01-01
- MeSH
- aktivace enzymů MeSH
- beta-N-acetylhexosaminidasy chemie genetika metabolismus MeSH
- hydrolýza MeSH
- kinetika MeSH
- koncentrace vodíkových iontů MeSH
- lidé MeSH
- molekulární konformace MeSH
- molekulární modely MeSH
- mutace MeSH
- polysacharidy biosyntéza chemie farmakologie MeSH
- proteinové inženýrství MeSH
- vodíková vazba MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
N-Acetylhexosamine oligosaccharides terminated with GalNAc act as selective ligands of galectin-3, a biomedically important human lectin. Their synthesis can be accomplished by β-N-acetylhexosaminidases (EC 3.2.1.52). Advantageously, these enzymes tolerate the presence of functional groups in the substrate molecule, such as the thiourea linker useful for covalent conjugation of glycans to a multivalent carrier, affording glyconjugates. β-N-Acetylhexosaminidases exhibit activity towards both N-acetylglucosamine (GlcNAc) and N-acetylgalactosamine (GalNAc) moieties. A point mutation of active-site amino acid Tyr into other amino acid residues, especially Phe, His, and Asn, has previously been shown to strongly suppress the hydrolytic activity of β-N-acetylhexosaminidases, creating enzymatic synthetic engines. In the present work, we demonstrate that Tyr470 is an important mutation hotspot for altering the ratio of GlcNAcase/GalNAcase activity, resulting in mutant enzymes with varying affinity to GlcNAc/GalNAc substrates. The enzyme selectivity may additionally be manipulated by altering the reaction medium upon changing pH or adding selected organic co-solvents. As a result, we are able to fine-tune the β-N-acetylhexosaminidase affinity and selectivity, resulting in a high-yield production of the functionalized GalNAcβ4GlcNAc disaccharide, a selective ligand of galectin-3.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19027828
- 003
- CZ-PrNML
- 005
- 20190815114635.0
- 007
- ta
- 008
- 190813s2019 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/molecules24030599 $2 doi
- 035 __
- $a (PubMed)30743988
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Bojarová, Pavla $u Laboratory of Biotransformation, Institute of Microbiology, Czech Academy of Sciences, Vídeňská 1083, CZ-14220 Praha 4, Czech Republic. bojarova@biomed.cas.cz.
- 245 14
- $a The β-N-Acetylhexosaminidase in the Synthesis of Bioactive Glycans: Protein and Reaction Engineering / $c P. Bojarová, N. Kulik, M. Hovorková, K. Slámová, H. Pelantová, V. Křen,
- 520 9_
- $a N-Acetylhexosamine oligosaccharides terminated with GalNAc act as selective ligands of galectin-3, a biomedically important human lectin. Their synthesis can be accomplished by β-N-acetylhexosaminidases (EC 3.2.1.52). Advantageously, these enzymes tolerate the presence of functional groups in the substrate molecule, such as the thiourea linker useful for covalent conjugation of glycans to a multivalent carrier, affording glyconjugates. β-N-Acetylhexosaminidases exhibit activity towards both N-acetylglucosamine (GlcNAc) and N-acetylgalactosamine (GalNAc) moieties. A point mutation of active-site amino acid Tyr into other amino acid residues, especially Phe, His, and Asn, has previously been shown to strongly suppress the hydrolytic activity of β-N-acetylhexosaminidases, creating enzymatic synthetic engines. In the present work, we demonstrate that Tyr470 is an important mutation hotspot for altering the ratio of GlcNAcase/GalNAcase activity, resulting in mutant enzymes with varying affinity to GlcNAc/GalNAc substrates. The enzyme selectivity may additionally be manipulated by altering the reaction medium upon changing pH or adding selected organic co-solvents. As a result, we are able to fine-tune the β-N-acetylhexosaminidase affinity and selectivity, resulting in a high-yield production of the functionalized GalNAcβ4GlcNAc disaccharide, a selective ligand of galectin-3.
- 650 _2
- $a aktivace enzymů $7 D004789
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a vodíková vazba $7 D006860
- 650 _2
- $a koncentrace vodíkových iontů $7 D006863
- 650 _2
- $a hydrolýza $7 D006868
- 650 _2
- $a kinetika $7 D007700
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a molekulární konformace $7 D008968
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a polysacharidy $x biosyntéza $x chemie $x farmakologie $7 D011134
- 650 _2
- $a proteinové inženýrství $7 D015202
- 650 _2
- $a beta-N-acetylhexosaminidasy $x chemie $x genetika $x metabolismus $7 D001619
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kulik, Natalia $u Center for Nanobiology and Structural Biology, Institute of Microbiology, Czech Academy of Sciences, Zámek 136, CZ-37333 Nové Hrady, Czech Republic. kulik@nh.cas.cz.
- 700 1_
- $a Hovorková, Michaela $u Laboratory of Biotransformation, Institute of Microbiology, Czech Academy of Sciences, Vídeňská 1083, CZ-14220 Praha 4, Czech Republic. michaela.hovorkova@natur.cuni.cz.
- 700 1_
- $a Slámová, Kristýna $u Laboratory of Biotransformation, Institute of Microbiology, Czech Academy of Sciences, Vídeňská 1083, CZ-14220 Praha 4, Czech Republic. slamova.kristyna@gmail.com.
- 700 1_
- $a Pelantová, Helena $u Laboratory of Molecular Structure Characterization, Institute of Microbiology, Czech Academy of Sciences, Vídeňská 1083, CZ-14220 Praha 4, Czech Republic. pelantova@biomed.cas.cz.
- 700 1_
- $a Křen, Vladimír $u Laboratory of Biotransformation, Institute of Microbiology, Czech Academy of Sciences, Vídeňská 1083, CZ-14220 Praha 4, Czech Republic. kren@biomed.cas.cz.
- 773 0_
- $w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 24, č. 3 (2019)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30743988 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20190815114903 $b ABA008
- 999 __
- $a ok $b bmc $g 1432977 $s 1066288
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 24 $c 3 $e 20190208 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
- GRA __
- $a LTC18038 $p Ministerstvo Školství, Mládeže a Tělovýchovy
- LZP __
- $a Pubmed-20190813